Smith, Moore & Co’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,000
Closed -$24K 334
2018
Q4
$24K Hold
10,000
0.01% 321
2018
Q3
$71K Hold
10,000
0.02% 348
2018
Q2
$111K Hold
10,000
0.03% 331
2018
Q1
$92K Hold
10,000
0.02% 317
2017
Q4
$95K Hold
10,000
0.03% 300
2017
Q3
$107K Buy
+10,000
New +$92.1K 0.03% 302

Other funds holding HHS

Smith, Moore & Co's HHS Position: Q1 2019 in Review

Smith, Moore & Co sold out of Harte-Hanks (HHS) in Q1 2019, closing a stake of 10,000 shares — an estimated $24K sold.

Smith, Moore & Co first reported a position in HHS in Q3 2017 and held it in 6 quarters. The position peaked at $111K in Q2 2018. 22 funds tracked by Wall St. Rank hold HHS as of Q1 2019.

  • Smith, Moore & Co reported no remaining Harte-Hanks position as of Q1 2019 after selling out during the quarter.
  • Smith, Moore & Co sold 10,000 Harte-Hanks shares in Q1 2019, an estimated $24K.
  • Smith, Moore & Co first reported a position in Harte-Hanks in Q3 2017 and held it in 6 quarters.
  • Smith, Moore & Co's Harte-Hanks position peaked at $111K in Q2 2018.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2019.

Based on Smith, Moore & Co's 13F filing for Q1 2019, filed 7 May 2019.